Ioannis D. Gkegkes

Dr. Ioannis D. Gkegkes

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Minimal Access Surgery
Verified
Journal Article
Open access
IGIoannis D. Gkegkes
Ioannis D. Gkegkes
IMIoannis Mamais
Ioannis Mamais
CIChristos Iavazzo
Christos Iavazzo
Ic way to retrieve the included studies in our review. Thirty-one studies were retrieved, referring on a vast range of surgical operations. The mean cost for robotic, open and laparoscopic ranged from 2539 to 57,002, 7888 to 16,851 and 1799 to 50,408 Euros, respectively. The mean operative charges ranged from 273.74 to 13,670 Euros. More specifically, for the robotic and laparoscopic gastric fundoplication, the cost ranged from 1534 to 2257 and 657 to 763 Euros, respectively. For the robotic and laparoscopic colectomy, it ranged from 3739 to 17,080 and 3109 to 33,865 Euros, respectively. For the robotic and laparoscopic cholecystectomy, ranged from 1163.75 to 1291 and from 273.74 to 1223 Euros, respectively. The mean non-operative costs ranged from 900 to 48,796 from 8347 to 8800 and from 870 to 42,055 Euros, for robotic, open and laparoscopic technique, respectively. Conversions to laparotomy were present in 34/18,620 (0.18%) cases of laparoscopic and in 22/1488 (1.5%) cases of robotic technique. Duration of surgery robotic, open and laparoscopic ranged from 54.6 to 328.7, 129 to 234, and from 50.2 to 260 min, respectively. The present evidence reveals that robotic surgery, under specific conditions, has the potential to become cost-effective. Large number of cases, presence of industry competition and multidisciplinary team utilisation are some of the factors that could make more reasonable and cost-effective the robotic-assisted technique....

11 January 2019 in Digestive Surgery
Verified
Journal Article
Open access
PDF file
IGIoannis D. Gkegkes
Ioannis D. Gkegkes
EMEvelyn Eleni Minis
Evelyn Eleni Minis
CIChristos Iavazzo
Christos Iavazzo
Background: Postoperative ileus prolongs both hospital stay and patients’ morbidity, having at the same time a great impact on health care costs. Coffee, a worldwide popular, cheap beverage might have an important effect on the motility of the postoperative bowel. Methods: PubMed, Scopus, and Cochrane Central Register of Controlled Trials were systematically searched. Results: Four studies met the inclusion criteria of our meta-analysis. A total of 341 patients were included. The postoperative administration of coffee significantly reduces the time to first bowel movement, the time to first flatus and the time to tolerance of solid diet. Safe conclusions could not be drawn regarding the additional use of laxatives, the necessity for reinsertion of nasogastric tube or the need for reoperation as all the aforementioned outcomes did not present any statistically significance. None of the complications were attributed to the administration of coffee. Conclusion: The administration of coffee as a postoperative ileus prevention measure can change the way postoperative enhanced recovery is applied. Even though the mechanism of action of coffee is not fully known, currently available literature demonstrates a significant improvement in gastrointestinal motility without having any impact on postoperative morbidity. Studies with higher methodological quality can offer a more careful evaluation of the clinical use of this popular beverage.

1 September 2020 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Closed access
DMDespoina Mortaki
Despoina Mortaki
IGIoannis D. Gkegkes
Ioannis D. Gkegkes
VPVictoria Psomiadou
Victoria Psomiadou
NBNikolaos Blontzos
Nikolaos Blontzos
APAnastasia Prodromidou
Anastasia Prodromidou
ENElectra Nicolaidou
Electra Nicolaidou
Accumulating evidence indicates the potential correlation between the vaginal microbioma and the acquisition and persistence of Human Papillomavirus (HPV) infection. This study has as intention to demonstrate the potential relationship through a systematic review of the current literature. A search was conducted on the following medical databases: PubMed and Scopus. Nineteen studies were meeting our inclusion criteria and, finally, incorporated, in the present review. A total of 12,204 patients and their demographic characteristics were studied. Commercially available DNA tests and PCR were used for the detection of different HPV subtypes, while the identification of the microbiomes was performed through specific diagnostic methods and PCR assay. The most frequently encountered species were classified based on their protective or detrimental impact on the progression of HPV infection. The beneficial role of some types of Lactobacillus (Lactobacillus gasseri, Lactobacillus jensenii, Lactobacillus crispatus) is generally supported. On the other hand, high microbial diversity and specific microorganisms such as Sneathia, Anaerococcus tetradius, Peptostreptococcus, Fusobacterium and Gardnerella vaginalis were found to be implicated with higher frequency and severity of disease, potentially resulting in pre-cancerous and cancerous cervical lesions. The role of vaginal microbiota seems to play a -yet not fully understood- role concerning the susceptibility to HPV infection and its natural history.

5 May 2018 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
IGIoannis D. Gkegkes
Ioannis D. Gkegkes
EMEvelyn Eleni Minis
Evelyn Eleni Minis
CIChristos Iavazzo
Christos Iavazzo

1 May 2023 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
Panagiotis PeitsidisPanagiotis Peitsidis
Panagiotis Peitsidis
PANAGIOTIS TSIKOURASPANAGIOTIS TSIKOURAS
PANAGIOTIS TSIKOURAS
Antonio Simone LaganàAntonio Simone Laganà
Antonio Simone Laganà
Alexandros LaiosAlexandros Laios
Alexandros Laios
IGIoannis D. Gkegkes
Ioannis D. Gkegkes
Christos R. IavazzoChristos R. Iavazzo
Christos R. Iavazzo
Endometriosis is a chronic gynecologic condition that affects around 6– 10% of reproductive age women. This clinical entity is characterized with pelvic pain, dysmenorrhea, dyspareunia, and infertility which are the most often presenting symptoms. Aromatase P450 is the key enzyme for ovarian estrogen biosynthesis and there is evidence that endometriotic lesions express aromatase and are able to synthesize their own estrogens. Aromatase inhibitors (AIs) are potent drugs that suppress the estrogen synthesis via suppression of aromatase. We performed a systematic review of systematic reviews and narrative reviews on the use of aromatase inhibitors in the medical management of endometriosis. We searched: PubMed (1950– 2022), Google Scholar (2004– 2022), Cochrane Library (2010– 2022) and Researchgate (2010– 2022). The search included the following medical subject headings (MeSH) or keywords: “Aromatase Inhibitors” AND “Endometriosis” AND “Systematic reviews” OR “Systematic review” AND “Reviews” OR “Reviews” AND “Endometriosis”. The electronic database search yielded initially 12,106 studies from the different databases. Further assessment of the studies resulted in exclusion of (n = 12,015) studies due to duplicates and irrelevance; Finally, 24 studies were selected for inclusion, 5 were Systematic reviews and 19 were Narrative reviews. The 5 systematic reviews were assessed by AMSTAR-2 criteria and were found to have low quality. Narrative reviews were assessed with SANRA criteria and were found to have high-quality aromatase inhibitors are potent drugs that can manage the endometriosis-related symptoms in cases where initial medical management has failed to show positive results. However, their use is limited by the adverse effects that are linked with menopausal symptoms. aromatase inhibitors can be administered as an alternative treatment in patients. Future studies with randomized design are required to reach safer conclusions and further investigation. These studies should define the therapeutic dose, new add-back therapy modalities. Future directions should examine the most-appropriate way of administration and the duration of therapy.

1 January 2015 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
IGIoannis Gakidis
Ioannis Gakidis
IGIoannis D. Gkegkes
Ioannis D. Gkegkes
SMSarantis Mourtarakos
Sarantis Mourtarakos
Background: Persistent air leak is one of the most common complications of lung diseases and pulmonary resections. Prolonged hospitalization, increased morbidity, and increased overall treatment costs arise from persistent air leaks. The use...